v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Common Class A [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI, Equity Method Investment, Including Noncontrolling Interest [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2024 $ 3.00 $ 119 $ 195,864,697 $ (190,541,067) $ 5,323,752 $ (51,941) $ 5,271,811
Balance, shares at Dec. 31, 2024 26,972 1,183,942          
Net loss to common stockholders (788,583) (788,583) (788,583)
Noncontrolling interest (4,350) (4,350)
Common stock issued for conversions of Series A Preferred Stock $ 7 (7)
Common stock issued for conversions of Series A Preferred Stock, shares (308) 73,374         217,302
Common stock issued under terms of notes payable $ 3 38,247 38,250 $ 38,250
Common stock issued under terms of notes payable, shares   30,752          
Stock-based compensation 27,716 27,716 27,716
Issuances of Series B Preferred Stock in exchange for Senior PIK Notes, net of finder’s fees 3,282,500 3,282,500 3,282,500
Issuances of Series B Preferred Stock in exchange for Senior PIK Notes, net of finder's fees, shares 3,457            
Issuances of Series C Preferred Stock for cash investments, net of finder’s fees 44,825 44,825 44,825
Issuances of Series C Preferred Stock for cash investments, net of finder's fees, shares 60            
Exchanges of Series B Preferred Stock for Series C Preferred Stock
Exchanges of Series B Preferred Stock for Series C Preferred Stock, shares 75            
Common stock issued for conversions and exchanges of notes payable $ 22 828,452 828,474 828,474
Common stock issued for conversions and exchanges of notes payable, shares   217,302          
Common stock issuable under terms of notes payable 68,225 68,225 68,225
Common stock issued and issuable for finder’s fees $ 1 141,189 141,190 141,190
Common stock issued and issuable for finder's fees, shares   11,494          
Shares issued under Corporate Development and Advisory Agreement $ 4 (4)
Shares issued under Corporate Development and Advisory Agreement, shares   38,389          
Common stock issued for legal settlement $ 17 570,646 570,663   570,663
Common stock issued for legal settlement, shares   165,077          
Deemed dividends from issuances of preferred stock and triggers of down round provisions of Assumed Warrants 172,125 172,125 172,125
Balance at Mar. 31, 2025 $ 3 $ 173 201,038,611 (191,329,650) 9,709,137 (56,291) 9,652,846
Balance, shares at Mar. 31, 2025 30,256 1,720,330          
Balance at Dec. 31, 2025 $ 10 $ 249,566 235,540,145 (224,644,739) 11,144,982 (68,682) 11,076,300
Balance, shares at Dec. 31, 2025 95,202 2,495,660,151          
Net loss to common stockholders (1,451,973) (1,451,973) (1,451,973)
Noncontrolling interest (3,213) (3,213)
Common stock issued for conversions of Series A Preferred Stock $ (0) $ 108,700 (108,700)
Common stock issued for conversions of Series A Preferred Stock, shares (109) 1,087,000,000          
Common stock issued under terms of notes payable $ 15,000   15,000 15,000
Common stock issued under terms of notes payable, shares   150,000,000          
Balance at Mar. 31, 2026 $ 10 $ 373,266 $ 235,431,445 $ (226,096,712) $ 9,708,009 $ (71,895) $ 9,636,114
Balance, shares at Mar. 31, 2026 95,093 3,732,660,151